Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleic Acid Therapeutics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118955591B discloses novel nucleoside monomers reducing off-target effects. Enhance supply chain reliability and cost efficiency in oligonucleotide manufacturing.
Patent CN100354295C discloses novel 2'-O-silyloxymethyl protecting groups enabling faster deprotection and higher coupling yields for cost-effective oligoribonucleotide manufacturing.
Patent CN113423714A details a novel sulfonylation route for 3'-O-amino-ribonucleotides, offering improved selectivity and scalability for nucleic acid manufacturing.